Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 649.04 (+0.32%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 649.04 (+0.32%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 649.04 (+0.32%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 137.02 (+0.27%)
CHE : 649.04 (+0.32%)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore...

CHE : 649.04 (+0.32%)
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View

AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.

ISRG : 392.62 (-0.92%)
ABC : 179.98 (-0.23%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves

Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.

SYK : 354.08 (+0.53%)
ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong

DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
DXCM : 134.72 (+3.27%)
CHE : 649.04 (+0.32%)
Baxter (BAX) Beats on Q1 Earnings, Ups '23 EPS View

Baxter's (BAX) first-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.

BAX : 41.54 (-0.17%)
ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
West Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong

West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.

ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
WST : 395.72 (+2.09%)
CHE : 649.04 (+0.32%)

Barchart Exclusives

3 AI Chip Stocks That Look More Overvalued Than Nvidia Right Now
The breakout rally in AI stocks, with Nvidia leading the charge, has raised concerns about a potential bubble. However, with NVDA now down about 10% from its recent highs, here are three AI chip stocks that look even more expensive than the industry leader. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar